
1NKEMIA — Investor Relations & Filings
1NKEMIA is a biotechnology company focused on generating high-value technological knowledge for the life sciences sector. The company's activities are structured around four main areas: Open R&D and innovation, technological services, specialized training, and the management of a knowledge capital fund. It provides services such as analytical development and validation to a diverse client base in the chemical, pharmaceutical, biotechnological, cosmetic, and nutraceutical industries. Operating as a group, 1NKEMIA also holds interests in various specialized companies to foster technological advancement and collaboration within its target markets.
Recent filings
No filings indexed yet
We are still gathering filings for 1NKEMIA. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ecopia BioSciences Inc.
Developing novel anticancer agents and therapeutic solution…
|
EIA | CA | Professional, scientific and te… |
|
Ectin Research AB
Pharmaceutical company developing novel oncology treatments…
|
ECTIN B | SE | Professional, scientific and te… |
|
EdgeLab S.p.A.
Designs and manufactures marine and underwater solutions, i…
|
ELB | IT | Professional, scientific and te… |
|
Editas Medicine, Inc.
A clinical-stage genome editing company developing CRISPR m…
|
EDIT | US | Professional, scientific and te… |
|
EGF Theramed Health Corp.
Developing psychedelic drugs for mental health, diagnostic …
|
TMED | CA | Professional, scientific and te… |
|
Eikon Therapeutics, Inc.
Integrates live-cell imaging and computing to discover ther…
|
EIKN | US | Professional, scientific and te… |
|
Eledon Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for organ and a…
|
ELDN | US | Professional, scientific and te… |
|
Elicera Therapeutics AB
Clinical-stage immuno-oncology company developing cell and …
|
ELIC | SE | Professional, scientific and te… |
|
Elicio Therapeutics, Inc.
Clinical-stage biotech developing lymph node-targeted immun…
|
ELTX | US | Professional, scientific and te… |
|
ELSOFT RESEARCH BERHAD
Develops cost-effective test & burn-in systems, embedded sy…
|
— | MY | Professional, scientific and te… |
1NKEMIA via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/9193/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=9193 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=9193 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=9193 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 9193}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 1NKEMIA (id: 9193)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.